ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy.

Proc Natl Acad Sci U S A

Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104;

Published: June 2021

AI Article Synopsis

  • TBK1 is crucial for mitophagy, and over 90 mutations in this enzyme are linked to ALS and fronto-temporal dementia, affecting its functions in ways that can disrupt mitochondrial clearance.
  • Some mutations severely disrupt the mitophagy pathway, while others only cause mild effects; TBK1’s ability to dimerize and its kinase activity are important but not solely responsible for its function.
  • The study highlights that TBK1 mutations can cause mitochondrial stress, contributing to ALS progression, but the impact of these mutations may vary depending on cell types and other related pathways.

Article Abstract

TANK-binding kinase 1 (TBK1) is a multifunctional kinase with an essential role in mitophagy, the selective clearance of damaged mitochondria. More than 90 distinct mutations in TBK1 are linked to amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia, including missense mutations that disrupt the abilities of TBK1 to dimerize, associate with the mitophagy receptor optineurin (OPTN), autoactivate, or catalyze phosphorylation. We investigated how ALS-associated mutations in TBK1 affect Parkin-dependent mitophagy using imaging to dissect the molecular mechanisms involved in clearing damaged mitochondria. Some mutations cause severe dysregulation of the pathway, while others induce limited disruption. Mutations that abolish either TBK1 dimerization or kinase activity were insufficient to fully inhibit mitophagy, while mutations that reduced both dimerization and kinase activity were more disruptive. Ultimately, both TBK1 recruitment and OPTN phosphorylation at S177 are necessary for engulfment of damaged mitochondra by autophagosomal membranes. Surprisingly, we find that ULK1 activity contributes to the phosphorylation of OPTN in the presence of either wild-type or kinase-inactive TBK1. In primary neurons, TBK1 mutants induce mitochondrial stress under basal conditions; network stress is exacerbated with further mitochondrial insult. Our study further refines the model for TBK1 function in mitophagy, demonstrating that some ALS-linked mutations likely contribute to disease pathogenesis by inducing mitochondrial stress or inhibiting mitophagic flux. Other TBK1 mutations exhibited much less impact on mitophagy in our assays, suggesting that cell-type-specific effects, cumulative damage, or alternative TBK1-dependent pathways such as innate immunity and inflammation also factor into the development of ALS in affected individuals.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214690PMC
http://dx.doi.org/10.1073/pnas.2025053118DOI Listing

Publication Analysis

Top Keywords

mutations tbk1
12
tbk1
11
mutations
9
missense mutations
8
damaged mitochondria
8
dimerization kinase
8
kinase activity
8
mitochondrial stress
8
mitophagy
7
als- ftd-associated
4

Similar Publications

Heme is known to bind to the intrinsically disordered region (IDR) to regulate protein function. The binding of heme to the IDR of transcription factor BACH2 promotes plasma cell differentiation, but the molecular basis is unknown. Heme was found to increase BACH2 IDR interaction with TANK-binding kinase 1 (TBK1).

View Article and Find Full Text PDF
Article Synopsis
  • Endometrial cancer is a serious gynecological issue, and the study focused on the role of TBK1, a kinase involved in inflammation and immunity, in this cancer type.
  • Research found that low TBK1 expression is linked to better patient outcomes, and inhibiting TBK1 with amlexanox reduced cancer cell growth and migration.
  • The effects of amlexanox were shown to work through the AKT/NF-κB signaling pathway, suggesting a new direction for cancer treatments targeting TBK1 in endometrial cancer.
View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is a devastating, uniformly lethal degenerative disease of motor neurons, presenting with relentlessly progressive muscle atrophy and weakness. More than fifty genes carrying causative or disease-modifying variants have been identified since the 1990s, when the first ALS-associated variant in the gene SOD1 was discovered. The most commonly mutated ALS genes in the European populations include the C9orf72, SOD1, TARDBP and FUS.

View Article and Find Full Text PDF
Article Synopsis
  • Macroautophagy involves creating structures called autophagosomes for cellular cleanup, and disrupting their closure has unknown effects.
  • Researchers created mice with a specific mutation that impairs autophagosome closure, resulting in various issues like protein buildup and growth problems, though some survive into adulthood.
  • The study found that this mutation causes the buildup of a protein (TBK1) on forming autophagosomes, leading to increased phosphorylation and aggregation of other proteins, suggesting a new role for these structures in managing cellular waste.
View Article and Find Full Text PDF

Targeting ATAD3A Phosphorylation Mediated by TBK1 Ameliorates Senescence-Associated Pathologies.

Adv Sci (Weinh)

January 2025

Guangdong Cardiovascular Institute, Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.

Targeting cellular senescence, one of the hallmarks of aging and aging-related pathologies emerges as an effective strategy for anti-aging and cancer chemotherapy. Here, a switch from TBK1-OPTN axis to TBK1-ATAD3A axis to promote cellular senescence is shown. Mechanically, TBK1 protein is abnormally activated and localized to the mitochondria during senescence, which directly phosphorylates ATAD3A at Ser321.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!